Treace Medical Concepts (TMCI) CEO John T. Treace reports 19.2% beneficial stake

Rhea-AI Filing Summary

Treace Medical Concepts, Inc. reported that its Chief Executive Officer, John T. Treace, filed an amended Schedule 13G reflecting his ownership in the company’s common stock as of June 30, 2026. Based on 64,976,624 shares of common stock outstanding, he may be deemed the beneficial owner of 12,530,959 shares, representing 19.2% of the class.

The position includes shares held directly by John T. Treace, multiple family trusts for which he or his spouse serve as trustee or co-trustee, his spouse’s holdings, and 401,175 shares underlying stock options that are currently exercisable or will be exercisable within 60 days of June 30, 2026. He has 9,045,893 shares with sole voting and dispositive power and 3,485,066 shares with shared voting and dispositive power.

Key Figures

Shares outstanding: 64,976,624 shares Beneficial ownership shares: 12,530,959 shares Percent of class: 19.2% +4 more

7 metrics

Shares outstanding 64,976,624 shares Common stock outstanding as of June 30, 2026, used for ownership calculation

Beneficial ownership shares 12,530,959 shares Shares of Treace Medical Concepts common stock beneficially owned by John T. Treace

Percent of class 19.2% Portion of Treace Medical Concepts common stock beneficially owned by John T. Treace

Sole voting power 9,045,893 shares Shares over which John T. Treace has sole power to vote or direct the vote

Shared voting power 3,485,066 shares Shares over which John T. Treace has shared power to vote or direct the vote

Options exercisable within 60 days 401,175 shares Shares underlying stock options currently exercisable or exercisable within 60 days of June 30, 2026

Shares held by spouse 1,605,000 shares Common stock held of record by John T. Treace’s spouse included in beneficial ownership

Key Terms

beneficial owner, sole voting power, shared dispositive power, stock options, +1 more

5 terms

beneficial owner financial

"John T. Treace may be deemed the beneficial owner of 12,530,959 shares of Common Stock"

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

sole voting power financial

"Sole power to vote or to direct the vote: 9,045,893"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

shared dispositive power financial

"Shared power to dispose or to direct the disposition of: 3,485,066"

stock options financial

"401,175 shares of Common Stock underlying stock options that are either currently exercisable"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

Schedule 13G regulatory

"The ownership information presented below represents beneficial ownership of Common Stock ... Schedule 13G"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

What percentage of Treace Medical Concepts (TMCI) does John T. Treace own?

As of June 30, 2026, John T. Treace may be deemed to beneficially own 19.2% of Treace Medical Concepts’ common stock, representing 12,530,959 shares out of 64,976,624 shares of common stock outstanding.

How many Treace Medical Concepts (TMCI) shares does John T. Treace beneficially own?

John T. Treace may be deemed to beneficially own 12,530,959 shares of Treace Medical Concepts common stock. This total includes direct holdings, family trust and spouse holdings, and 401,175 shares underlying stock options exercisable within 60 days.

What is the total number of Treace Medical Concepts (TMCI) shares outstanding used in this filing?

The beneficial ownership calculation is based on 64,976,624 shares of Treace Medical Concepts common stock outstanding as of June 30, 2026, as provided by the issuer and used to derive the reported 19.2% ownership stake.

How many TMCI shares does John T. Treace control with sole versus shared voting power?

John T. Treace has sole voting power over 9,045,893 shares of Treace Medical Concepts common stock and shared voting power over 3,485,066 shares, matching his sole and shared dispositive power over the same respective amounts.

What portion of John T. Treace’s TMCI holdings are stock options?

His beneficial ownership includes 401,175 shares of Treace Medical Concepts common stock underlying stock options that are currently exercisable or will be exercisable within 60 days of June 30, 2026, in addition to directly and indirectly held shares.

How are family trusts and spouse holdings treated in John T. Treace’s TMCI ownership?

The reported 12,530,959 shares include stock held by family trusts where John T. Treace or his spouse serve as trustee or co-trustee, and 1,605,000 shares held of record by his spouse, which are all included in his beneficial ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/12/2026 - 05:32 PM Accepted by SEC EDGAR 08/12/2026 - 05:32 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 4)

Treace Medical Concepts, Inc.

(Name of Issuer)

Common Stock, $0.001 par value

(Title of Class of Securities)

89455T109

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 89455T109

1

Names of Reporting Persons

John T. Treace

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 9,045,893.00
6	Shared Voting Power 3,485,066.00
7	Sole Dispositive Power 9,045,893.00
8	Shared Dispositive Power 3,485,066.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

12,530,959.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

19.2 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Treace Medical Concepts, Inc.
(b)	Address of issuer's principal executive offices: 100 Palmetto Park Place, Ponte Vedra, Florida 32081
Item 2.
(a)	Name of person filing: This statement is filed on behalf of John T. Treace (the "Reporting Person").
(b)	Address or principal business office or, if none, residence: The business address of the Reporting Person is c/o Treace Medical Concepts, Inc., 100 Palmetto Park Place, Ponte Vedra, Florida 32081.
(c)	Citizenship: The Reporting Person is a citizen of the United States.
(d)	Title of class of securities: Common Stock, $0.001 par value
(e)	CUSIP No.: 89455T109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The ownership information presented below represents beneficial ownership of Common Stock of Treace Medical Concepts, Inc. (the "Issuer") as of June 30, 2026, based upon 64,976,624 shares of Common Stock outstanding as of June 30, 2026, as provided by the Issuer. John T. Treace may be deemed the beneficial owner of 12,530,959 shares of Common Stock, which includes (i) 6,805,655 shares of Common Stock held of record by the Reporting Person, (ii) 1,839,063 shares of Common Stock held of record by a family trust, of which the Reporting Person is trustee, (iii) 1,605,000 shares of Common Stock held of record by Reporting Person's spouse, (iv) 1,471,250 shares of Common Stock held of record by a family trust, of which the Reporting Person's spouse is co-trustee, (v) 408,816 shares of Common Stock held of record by a family trust, of which the Reporting Person is co-trustee and (vi) 401,175 shares of Common Stock underlying stock options that are either currently exercisable or will be exercisable within 60 days of June 30, 2026.
(b)	Percent of class: 19.2 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 9,045,893
	(ii) Shared power to vote or to direct the vote: 3,485,066
	(iii) Sole power to dispose or to direct the disposition of: 9,045,893
	(iv) Shared power to dispose or to direct the disposition of: 3,485,066
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

John T. Treace

Signature:	/s/ John T. Treace
Name/Title:	Chief Executive Officer
Date:	08/12/2026